Nexplanon (Organon USA Inc.)


Welcome to the PulseAid listing for the Nexplanon drug offered from Organon USA Inc.. This Progesterone Congeners [Chemical/Ingredient],Progestin [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view the details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: Organon USA Inc.
NON-PROPRIETARY NAME: etonogestrel
SUBSTANCE NAME: ETONOGESTREL
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: Progesterone Congeners [Chemical/Ingredient],Progestin [EPC]
ROUTE: SUBCUTANEOUS
DOSAGE FORM: IMPLANT
MARKETING CATEGORY NAME: NDA
START MARKETING DATE: 2006-07-17
END MARKETING DATE: 0000-00-00


Nexplanon HUMAN PRESCRIPTION DRUG Details:

Item DescriptionNexplanon from Organon USA Inc.
LABELER NAME: Organon USA Inc.
DEA SCHEDULE:
ACTIVE STRENGTH: 68(mg/1)
START MARKETING DATE: 2006-07-17
END MARKETING DATE: 0000-00-00
PRODUCT ID: 0052-0274_7dee8239-af76-48ba-bfbf-afd82194b69a
PRODUCT NDC: 0052-0274
APPLICATION NUMBER: NDA021529

Other ETONOGESTREL Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Organon USA Inc.IMPLANON